Impact of COVID-19 measures on exacerbation rates and healthcare visits in US asthma patients

COVID-19 pandemic impact on telehealth use and perceptions for atopic and respiratory disease: Survey results

(2022) Don A. Bukstein et al.   ALLERGY AND ASTHMA PROCEEDINGS

Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data

(2021) Syed A Shah et al.   THORAX

Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales

(2021) Gwyneth A Davies et al.   THORAX

Outcomes among patients with COVID-19 and asthma: A systematic review and meta-analysis

(2021) Andrea N. Sitek et al.   ALLERGY AND ASTHMA PROCEEDINGS

Intensity and frequency of extreme novel epidemics

(2021) Marco Marani et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Association of asthma comorbidity with poor prognosis of coronavirus disease 2019

(2021) Sae-Hoon Kim et al.   World Allergy Organization Journal

National decline in asthma exacerbations in United States during coronavirus disease 2019 pandemic

(2021) Regina W. Lam et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019

(2021) Saeid Safiri et al.   CHEST

COVID-19 lockdown dropped the rate of paediatric asthma admissions

(2020) Uros Krivec et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)

(2020) Christian Gessner et al.   RESPIRATORY MEDICINE

Assessment of Countries’ Preparedness and Lockdown Effectiveness in Fighting COVID-19

(2020) Faten Amer et al.   Disaster Medicine and Public Health Preparedness

Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study

(2020) Richard N van Zyl-Smit et al.   Lancet Respiratory Medicine

Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study

(2020) Huib A M Kerstjens et al.   Lancet Respiratory Medicine

Initial effects of the COVID-19 pandemic on pediatric asthma emergency department utilization

(2020) Chén C. Kenyon et al.   Journal of Allergy and Clinical Immunology-In Practice

Asthma and severe acute respiratory syndrome coronavirus 2019

(2020) Sara M. Assaf et al.   CURRENT OPINION IN PULMONARY MEDICINE

Global lockdown: An effective safeguard in responding to the threat of COVID ‐19

(2020) Bhupendra Kumar Verma et al.   JOURNAL OF EVALUATION IN CLINICAL PRACTICE

It is unprecedented: trial management during the COVID-19 pandemic and beyond

(2020) Eleanor J. Mitchell et al.   Trials

Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review

(2018) Xue-yan Zheng et al.   ARCHIVES OF VIROLOGY

The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA

(2017) Robert Y. Suruki et al.   BMC Pulmonary Medicine

EAACI position statement on asthma exacerbations and severe asthma

(2013) A. Custovic et al.   ALLERGY

A retrospective cohort study assessing patient characteristics and the incidence of cardiovascular disease using linked routine primary and secondary care data

(2012) Rupert A Payne et al.   BMJ Open

Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma

(2010) Jean Bousquet et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

(2008) Erik von Elm et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY